Literature DB >> 26253411

Pancreatic involvement in pediatric inflammatory bowel diseases.

Sabrina Cardile1, Antonino Randazzo, Simona Valenti, Claudio Romano.   

Abstract

BACKGROUND: Inflammatory bowel diseases (IBDs) are a group of chronic diseases affecting the gastrointestinal tract, with a disabling course. The incidence of IBDs is increasing in different geographical areas, indicating its emergence as a global disease, especially in children. Many patients with IBDs develop extraintestinal manifestations (EIMs) during follow-up, as IBDs have a potential risk of systemic involvement.. DATA SOURCES: A systematic review of the literature was made to analyze latest studies on pancreatic involvement in children with IBD including our experience in assessing possible implications and its future application.
RESULTS: The involvement of the hepatobiliary system is considered a rare EIM of children with IBD, with an incidence much higher than that in the general population. Isolated pancreatic hyperenzymemia, which occurs in the absence of typical symptoms and/or characteristic imaging findings, may be found in many patients with IBD. The frequent causes of pancreatitis are drugs, bilio-pancreatic disorders, immunologic disturbances and pancreatic auto-antibodies, although in some cases idiopathic forms have been described.
CONCLUSIONS: It is important to establish a correct diagnostic approach based on etiology and to assess the most appropriate therapeutic strategy, thus avoiding complications and improving the quality of life of children with IBD.

Entities:  

Mesh:

Year:  2015        PMID: 26253411     DOI: 10.1007/s12519-015-0029-z

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  32 in total

1.  Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.

Authors:  B Heikius; S Niemelä; J Lehtola; T Karttunen; S Lähde
Journal:  Scand J Gastroenterol       Date:  1997-02       Impact factor: 2.423

Review 2.  The pancreas and inflammatory bowel diseases.

Authors:  K R Herrlinger; E F Stange
Journal:  Int J Pancreatol       Date:  2000-06

3.  Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.

Authors:  C Y Ooi; T D Bohane; D Lee; D Naidoo; A S Day
Journal:  Aliment Pharmacol Ther       Date:  2007-04-15       Impact factor: 8.171

4.  Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon.

Authors:  E J M van Geenen; N K H de Boer; P Stassen; R K Linskens; M J Bruno; C J J Mulder; C A Stegeman; A A van Bodegraven
Journal:  Aliment Pharmacol Ther       Date:  2010-03-06       Impact factor: 8.171

5.  Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease.

Authors:  Marta Kovacs; Peter Laszlo Lakatos; Maria Papp; Silvia Jacobsen; Eva Nemes; Marianne Polgar; Eniko Solyom; Piroska Bodi; Agnes Horvath; Katalin Eszter Muller; Kriszta Molnar; Doloresz Szabo; Aron Cseh; Antal Dezsofi; Andras Arato; Gabor Veres
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-10       Impact factor: 2.839

6.  Idiopathic pancreatitis preceding the diagnosis of inflammatory bowel disease is more frequent in pediatric patients.

Authors:  Efrat Broide; Iris Dotan; Batia Weiss; Michael Wilschanski; Baruch Yerushalmi; Aharon Klar; Arie Levine
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-06       Impact factor: 2.839

7.  Inflammatory bowel disease in the setting of autoimmune pancreatitis.

Authors:  Karthik Ravi; Suresh T Chari; Santhi S Vege; William J Sandborn; Thomas C Smyrk; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

8.  Recurrent Acute Pancreatitis and Therapy for Ulcerative Colitis.

Authors:  Jean Louis Frossard; Christian Felley; Pierre Michetti
Journal:  Case Rep Gastroenterol       Date:  2010-09-04

9.  Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.

Authors:  Folashade Adebisi Jose; Elizabeth A Garnett; Eric Vittinghoff; George D Ferry; Harland S Winter; Robert N Baldassano; Barbara S Kirschner; Stanley A Cohen; Benjamin D Gold; Oren Abramson; Melvin B Heyman
Journal:  Inflamm Bowel Dis       Date:  2009-01       Impact factor: 5.325

10.  [Pancreatic involvement in inflammatory bowel diseases in children].

Authors:  C Le Large-Guiheneuf; J P Hugot; C Faure; A Munck; J F Mougenot; J Navarro; J P Cézard
Journal:  Arch Pediatr       Date:  2002-05       Impact factor: 1.180

View more
  3 in total

Review 1.  Pancreatic disorders in inflammatory bowel disease.

Authors:  Filippo Antonini; Raffaele Pezzilli; Lucia Angelelli; Giampiero Macarri
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 2.  Pancreatic Involvement in Pediatric Inflammatory Bowel Disease.

Authors:  Javier Martín-de-Carpi; Melinda Moriczi; Gemma Pujol-Muncunill; Victor M Navas-López
Journal:  Front Pediatr       Date:  2017-10-11       Impact factor: 3.418

Review 3.  Pancreatic Associated Manifestations in Pediatric Inflammatory Bowel Diseases.

Authors:  Ugo Cucinotta; Claudio Romano; Valeria Dipasquale
Journal:  Genes (Basel)       Date:  2021-08-31       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.